INR 727.75
(2.18%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 3.59 Billion INR | -35.55% |
2022 | 5.58 Billion INR | -3.03% |
2021 | 5.75 Billion INR | 95.12% |
2020 | 2.94 Billion INR | 5.45% |
2019 | 2.79 Billion INR | 30.75% |
2018 | 2.13 Billion INR | 14.0% |
2017 | 1.87 Billion INR | 0.0% |
2016 | - INR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 2.89 Billion INR | 0.0% |
2024 Q1 | - INR | -100.0% |
2023 FY | 3.59 Billion INR | -35.55% |
2023 Q4 | 3.59 Billion INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 Q3 | - INR | -100.0% |
2023 Q2 | 5.56 Billion INR | 0.0% |
2022 Q4 | 5.58 Billion INR | 0.0% |
2022 FY | 5.58 Billion INR | -3.03% |
2022 Q1 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 5.48 Billion INR | 0.0% |
2021 FY | 5.75 Billion INR | 95.12% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 4.95 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q4 | 5.75 Billion INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 Q1 | - INR | -100.0% |
2020 FY | 2.94 Billion INR | 5.45% |
2020 Q4 | 2.94 Billion INR | 0.0% |
2020 Q2 | 2.72 Billion INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 FY | 2.79 Billion INR | 30.75% |
2019 Q4 | 2.79 Billion INR | 0.0% |
2019 Q3 | - INR | -100.0% |
2019 Q2 | 2.59 Billion INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2018 Q1 | - INR | -100.0% |
2018 FY | 2.13 Billion INR | 14.0% |
2018 Q2 | 2.12 Billion INR | 0.0% |
2018 Q4 | 2.13 Billion INR | 0.0% |
2017 Q4 | 1.87 Billion INR | 4.35% |
2017 FY | 1.87 Billion INR | 0.0% |
2017 Q3 | 1.79 Billion INR | 0.0% |
2016 FY | - INR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Ajanta Pharma Limited | 8.28 Billion INR | 56.577% |
Amrutanjan Health Care Limited | 289.04 Million INR | -1144.434% |
Sigachi Industries Limited | 707.2 Million INR | -408.621% |
Bal Pharma Limited | 878.11 Million INR | -309.628% |
Ind-Swift Laboratories Limited | 104.57 Million INR | -3339.571% |
Medico Remedies Limited | 163.37 Million INR | -2101.724% |
Lasa Supergenerics Limited | 190.43 Million INR | -1788.843% |
Venus Remedies Limited | 1.21 Billion INR | -195.587% |
Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
Alpa Laboratories Limited | 136.65 Million INR | -2532.214% |
Nectar Lifesciences Limited | 7.09 Billion INR | 49.277% |
Shilpa Medicare Limited | 3.44 Billion INR | -4.283% |
Aarti Drugs Limited | 4.85 Billion INR | 25.971% |
Lupin Limited | 49.53 Billion INR | 92.739% |
Aurobindo Pharma Limited | 98.08 Billion INR | 96.333% |
Zydus Lifesciences Limited | 34.41 Billion INR | 89.549% |
Windlas Biotech Limited | 621.89 Million INR | -478.398% |
Suven Life Sciences Limited | 7.08 Million INR | -50669.231% |
Eris Lifesciences Limited | 1.89 Billion INR | -90.285% |
Valiant Laboratories Limited | 100.15 Million INR | -3491.469% |
J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 28.419% |
Ipca Laboratories Limited | 24.71 Billion INR | 85.445% |
Bliss GVS Pharma Limited | 1.18 Billion INR | -203.679% |
Achyut Healthcare Limited | 568 Thousand INR | -633174.648% |
Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 96.355% |
Bajaj HealthCare Limited | 1.44 Billion INR | -149.725% |
RPG Life Sciences Limited | 1.01 Billion INR | -256.139% |
Mankind Pharma Limited | 15.53 Billion INR | 76.845% |
Laurus Labs Limited | 18.45 Billion INR | 80.508% |
Piramal Pharma Limited | 21.75 Billion INR | 83.469% |
Syncom Formulations (India) Limited | 210.81 Million INR | -1606.235% |
Torrent Pharmaceuticals Limited | 22.79 Billion INR | 84.217% |
Alembic Pharmaceuticals Limited | 16.43 Billion INR | 78.114% |
Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 85.687% |
Unichem Laboratories Limited | 7.04 Billion INR | 48.955% |
Sequent Scientific Limited | 3.46 Billion INR | -3.89% |
Novartis India Limited | 448.6 Million INR | -701.828% |
Wanbury Limited | 360.23 Million INR | -898.523% |
Suven Pharmaceuticals Limited | 2.31 Billion INR | -55.582% |
Wockhardt Limited | 6.4 Billion INR | 43.797% |
Themis Medicare Limited | 705.74 Million INR | -409.676% |
Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -2298.48% |
Jubilant Pharmova Limited | 12.89 Billion INR | 72.108% |
Glenmark Life Sciences Limited | 6.66 Billion INR | 46.039% |
Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 94.34% |
Divi's Laboratories Limited | 31.84 Billion INR | 88.703% |
NATCO Pharma Limited | 7 Billion INR | 48.651% |
Gufic Biosciences Limited | 2 Billion INR | -79.418% |
IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 15.333% |
Ind-Swift Limited | 640.91 Million INR | -461.229% |
Procter & Gamble Health Limited | 1.09 Billion INR | -229.667% |
FDC Limited | 3.88 Billion INR | 7.506% |
Krebs Biochemicals & Industries Limited | 97.96 Million INR | -3571.757% |
Granules India Limited | 13 Billion INR | 72.342% |
Medicamen Biotech Limited | 593.75 Million INR | -505.808% |
Alkem Laboratories Limited | 26.61 Billion INR | 86.483% |
AstraZeneca Pharma India Limited | 2.27 Billion INR | -57.845% |
Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -14007.542% |
Brooks Laboratories Limited | 96.1 Million INR | -3642.665% |
Megasoft Limited | - INR | -Infinity% |
ZIM Laboratories Limited | 812.62 Million INR | -342.637% |
Strides Pharma Science Limited | 11.26 Billion INR | 68.062% |
Neuland Laboratories Limited | 3.5 Billion INR | -2.648% |
Morepen Laboratories Limited | 2.48 Billion INR | -44.694% |
Hikal Limited | 3.03 Billion INR | -18.431% |
Indoco Remedies Limited | 3.53 Billion INR | -1.881% |
Aarti Pharmalabs Limited | 6.42 Billion INR | 44.047% |
Kilitch Drugs (India) Limited | 39.88 Million INR | -8919.559% |
Mangalam Drugs & Organics Limited | 1.23 Billion INR | -190.926% |
Hester Biosciences Limited | 755.81 Million INR | -375.913% |